GSK plc - SPONSORED ADR (GSK)

Historical Holders from Q1 2016 to Q3 2025

Symbol
GSK on NYSE
Type / Class
Equity / SPONSORED ADR
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
385,534,708
Holdings value
$16,641,555,049
% of all portfolios
0.022%
Number of holders
869
Number of buys
406
Number of sells
-382
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of GSK plc - SPONSORED ADR (GSK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 385,534,708 $16,641,555,049 +$149,423,139 $43.16 869
2025 Q2 377,323,511 $14,492,600,704 +$691,641,935 $38.4 873
2025 Q1 365,061,086 $14,138,125,686 +$1,006,993,911 $38.74 839
2024 Q4 340,917,752 $11,541,588,389 +$1,180,300,325 $33.82 833
2024 Q3 302,968,498 $12,377,977,607 -$140,106,119 $40.88 883
2024 Q2 309,126,756 $11,909,339,872 -$23,346,819 $38.5 869
2024 Q1 308,583,941 $13,222,947,461 +$833,173,631 $42.87 891
2023 Q4 289,484,844 $10,732,131,887 +$174,194,109 $37.06 882
2023 Q3 284,245,298 $10,307,406,122 +$264,432,361 $36.25 835
2023 Q2 276,495,626 $9,857,311,052 +$194,467,459 $35.64 814
2023 Q1 269,710,676 $9,600,329,935 -$208,079,525 $35.58 792
2022 Q4 276,203,256 $9,708,565,984 +$516,369,806 $35.14 788
2022 Q3 264,324,002 $7,785,299,734 +$7,652,922,694 $29.43 697
2022 Q2 4,250,301 $185,367,037 +$183,087,502 $43.53 67
2022 Q1 52,302 $2,281,067 -$356,058 $43.56 7
2021 Q4 60,336 $2,667,168 -$139,973 $44.1 7
2021 Q3 17,405 $671,931 +$7,790 $38.21 6
2021 Q2 17,188 $691,875 -$30,222 $39.82 6
2021 Q1 17,949 $649,577 +$393,265 $35.69 6
2020 Q4 7,178 $264,151 -$29,072 $36.8 4
2020 Q3 7,968 $299,261 +$325 $37.64 4
2020 Q2 7,971 $325,296 -$17,284 $40.79 3
2020 Q1 8,394 $316,305 -$7,502 $37.89 3
2019 Q4 8,592 $403,759 +$47 $46.99 3
2019 Q3 6,012 $256,603 +$43 $42.68 2
2019 Q2 6,011 $240,560 +$280 $40.02 2
2019 Q1 6,004 $250,926 -$58,469 $41.79 2
2018 Q4 7,403 $282,874 -$23,957 $38.21 2
2018 Q3 8,030 $322,558 -$357,464 $40.17 2
2018 Q2 16,929 $682,392 +$81 $40.31 2
2018 Q1 16,927 $661,338 +$10,158 $39.07 2
2017 Q4 16,667 $591,179 -$47,282 $35.47 2
2017 Q3 18,000 $730,800 -$109,620 $40.6 2
2017 Q2 20,700 $892,584 $43.12 2
2017 Q1 20,700 $872,712 $42.16 2
2016 Q4 20,700 $797,157 +$182,191 $38.51 2
2016 Q3 15,969 $688,743 +$10,783 $43.13 2
2016 Q2 15,719 $681,261 -$56,342 $43.34 2
2016 Q1 17,019 $690,120 $40.55 2